Dr Hendrik-Tobias Arkenau is Medical Director at Sarah Cannon Research UK in London.

Dr Arkenau received his medical and postgraduate degree at the Medical School Hanover, Germany, and completed his internship and specialist training in oncology in 2007. Before being appointed as, he was Senior Clinical Fellow at the Royal Marsden Hospital and team leader for Early Drug Development at the Prince of Wales Clinical School at the University of New South Wales, Sydney, Australia.

He has obtained ASCO, AACR and ESMO Merit Awards and languages spoken are English and German

Dr Frank Saran is a Consultant Clinical Oncologist based at The Royal Marsden Hospital.

Dr Saran moved to the Marsden in 2001 and is the head of the Neuro-Oncology Unit at The Marsden. Prior to this appointment he worked as a Consultant Clinical Oncologist at Velindre Hospital, Cardiff focussing on the management of primary CNS and spinal cord tumours as well as non-conformal radiotherapy for children with malignant tumours.

His academic and clinical focus is the management of patients requiring complex radiotherapy,conformal high-precision radiotherapy aiming to maximise tumour control while minimising the risk of potential long term side effects as well as novel systemic therapy approaches in primary CNS tumours. 

Dr Saran is regularly invited to give lectures on his subjects of expertise both internationally and nationally. He is member of many societies and national working groups including ESTRO, RCR, CCLG, NCRI Paediatric CNS tumour group and SIOP-E Brain Tumour Working Group.

Professor Derek Manas is a Consultant Hepatobiliary and Transplant Surgeon based in Newcastle.

Prof Manas trained in Cape Town, South Africa and completed fellowships at Johns Hopkins - USA and Paul-Brousse, Paris. He was the recipient of the CJ Adams/Sandoz Traveling Fellowship to the UK in 1993 and joined the NHS in Newcastle in 1994. 

Professor Manas attained a personal chair in Transplantation at Newcastle University in 2007 and has been instrumental in successfully developing three super-region funded transplant programmes (Liver, Pancreas and Islet transplantation) in the North East of England, as well as establishing and managing Liver and Pancreas cancer surgery in Newcastle. 

Professor Manas is a member of NICE, Liver and Pancreas Advisory Groups, British Transplant Society, ELTA. He was recently involved in re-designing the organ donor retrieval service on a national level. 

Dr Dawn Carnell is a Consultant Clinical Oncologist based at University College Hospital, London.

Dr Carnell is the clinical lead consultant clinical oncologist for lung cancer at UCH, and the lead consultant clinical oncologist in head and neck cancer. Her research (MD), sponsored by Cancer Research UK, and based at The Mount Vernon Cancer Centre, looked at hypoxia (low oxygen levels) in cancer and how this could be mapped histologically and using Blood Oxygen Level Dependent Magnetic Resonance Imaging. The future role for this would be to direct radiation boosts to radio-resistant hypoxic regions in cancer and to identify hypoxic tumours for specific treatments aimed at hypoxic cancer cells, translating to improved cure rates.

Dr Carnell also enjoys teaching and is one of the Lead Clinicians for Medical Student Teaching (the Head and Neck/Lung and CNS group) and contributes regularly to registrar teaching within oncology and ENT.

Dr David Propper is a Consultant Medical Oncologist based at Barts and The London NHS Trust.

Dr Propper trained in medical oncology at the Imperial Cancer Research Fund Medical Oncology Unit in Oxford and received major trial research experience there. He subsequently spent time at the Lombardi Cancer Centre Georgetown Washington DC, USA.

Dr Propper has interests in translational research, early phase trials and the introduction of new therapeutic agents.

Dr David Landau is a Consultant Clinical Oncologist at Guys and St. Thomas' NHS Trust.

Dr Landau qualified at Charing Cross and Westminster Medical School (now part of Imperial) in 1990. Most of his training in Clinical Oncology was at Charing Cross Hospital and he finished his training with clinical and research posts at The Royal Marsden Hospital.

Dr Landau now specialises only in cancers of the thorax, lung cancers, mesothelioma and thymoma. He also has a specialist interest in metastatic disease from many primaries. He has a particular interest in high-tech radiotherapy treatments.

Dr Landau is one of one founders of London Oncology Clinic in Harley Street and speaks English and French.

Dr David Feuer is a Consultant in Palliative Medicine based at Barts and The London NHS Trust.

Dr Feuer graduated from of The University of Southampton with degrees in Molecular Biology and Medicine. After training in a range of London hospitals, he became Senior Registrar & Research Fellow at The Royal Marsden NHS Trust. In this post he undertook a systematic review of The Management of Intestinal Obstruction due to advanced Gynaecological and Intestinal Cancer, funded by the NHS Executive Research and Development Fund. Numerous papers have resulted from this work, published in the specialist professional literature covering the fields of palliative medicine, general surgery, specialised gynecological oncology, and oncology.

Dr Feuers major interests include pathophysiology and the diagnosis and treatment of malignant intestinal obstruction, together with teaching focusing on the need for critical appraisal of the literature. He is passionate about the need for adequate palliative care and pain relief for all patients at any stage of their illness and  has made many presentations to local, national & international meetings, most notably as invited expert speaker to the NIH meeting in Los Angeles in 2004.

Professor Chris Nutting is a Professor of Clinical Oncology based at The Royal Marsden Hospital, London.

Prof Nutting is a world leading Oncologist.  Operating from his Central and West London practices, he specialises in the management of cancer of the head and head, thyroid, thorax and other forms. He is an expert in solid cancer treatment with state of the art radiotherapy techniques such as conformal and intensity modulated radiotherapy designed to reduce complications of treatment and improve cure rates.

In June 2001 Professor Nutting was appointed Consultant and Senior Lecturer in Clinical Oncology at the Royal Marsden Hospital, where his clinical responsibilities and special interests include the management of patients with head and neck and lung cancers. He is the Clinical Director of the Head and Neck Unit at the Royal Marsden Hospital in London.

He has an extensive clinical practice in head, neck and lung cancer and participates in Nation Research protocols. He is regularly asked to speak at National and International clinical meetings on head and neck and lung tumours.

Dr Christopher McNamara is a Consultant Haematologist based at The Royal Free Hospital NHS Foundation Trust in London.

Dr McNamara has with a special interest in lymphoma and difficult diagnostic problems. He holds Fellowships of the Royal Australasian College of Physicians and Pathologists and the Royal College of Pathologists.

His post-graduate training was in Brisbane, Melbourne and Paris. He has held an NHS appointment, based in lymphoma work in London for more than a decade.

 He has interests in:

• Follicular lymphoma
• Diffuse large B-cell lymphoma
• Hodgkin lymphoma
• Marginal zone lymphoma
• Mantle cell lymphoma
• Abnormal blood counts and their investigation

Dr McNamara is involved in applied clinical research in the lymphoma field as well as national and international clinical trials. 

Dr Chris Cottrill is a Consultant Clinical Oncologist based at Barts Cancer Centre (St Bartholomews Hospital) in London.

Dr Cottrill specialises in Breast and Gastrointestinal (oesophagus, stomach, pancreas, colon, rectum and anus) cancers and has a specialist interest in stereotactic radiosurgery (CyberKnife treatment). He has a particular interest in combined modality therapy (combination chemo-radiotherapy). He has been a Consultant at St Bartholomew's Hospital for 10 years and is experienced in all aspects of the chemotherapy and radiotherapy treatment of Breast and Gastrointestinal cancers.

Within the field of radiotherapy Dr Cottrill has a specialist interest in combined chemo-radiotherapy, intensity-modulated radiotherapy (IMRT, RapidArc, VMAT) and image-guided radiotherapy (IGRT). He is fully accredited in the use of CyberKnife stereotactic ablative radiotherapy (SABR) at Barts Hospital, the London Clinic and the Harley Street Clinic CyberKnife units.

Since 2000 Dr Cottrill has lectured annually on international postgraduate courses in the field of evidence-based radiation therapy for the European Society for Radiotherapy and Oncology (ESTRO).